Chargement en cours...
Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila
Polyglutamine (polyQ) diseases represent a group of progressive neurodegenerative disorders that are caused by abnormal expansion of CAG triplet nucleotides in disease genes. Recent evidence indicates that not only mutant polyQ proteins, but also their corresponding mutant RNAs, contribute to the pa...
Enregistré dans:
| Publié dans: | Dis Model Mech |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Company of Biologists Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833327/ https://ncbi.nlm.nih.gov/pubmed/26839389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1242/dmm.022350 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|